Ineffectiveness of oral coenzyme Q10 supplementation in 3-methylglutaconic aciduria, type 3
Coenzyme Q10 was administered under placebo controlled blinded crossover conditions to six subjects suffering from type 3 3-methylglutaconic aciduria (`optic atrophy plus'), following a report of benefit. Despite attainment of high plasma levels of coenzyme Q10, no clinical benefit was observed...
Gespeichert in:
Veröffentlicht in: | Brain & development (Tokyo. 1979) 1998, Vol.20 (1), p.33-35 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Coenzyme Q10 was administered under placebo controlled blinded crossover conditions to six subjects suffering from type 3 3-methylglutaconic aciduria (`optic atrophy plus'), following a report of benefit. Despite attainment of high plasma levels of coenzyme Q10, no clinical benefit was observed and there was no diminution of urinary excretion of 3-methylglutaconic acid. |
---|---|
ISSN: | 0387-7604 1872-7131 |
DOI: | 10.1016/S0387-7604(97)00096-X |